Plasma concentrations of vascular endothelial growth factor are associated with peripheral oedema in patients treated with thiazolidinedione.
Emoto
M
M
Fukuda
N
N
Nakamori
Y
Y
Taguchi
A
A
Okuya
S
S
Oka
Y
Y
Tanizawa
Y
Y
D000328:Adult; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004487:Edema / Q000097:blood* / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D045162:Thiazolidinediones / Q000009:adverse effects / Q000627:therapeutic use*; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*
D045162:Thiazolidinediones; D042461:Vascular Endothelial Growth Factor A; C089946:2,4-thiazolidinedione